1 Gwon DI, "Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study" 26 : 1589-1595, 2015
2 Yoon EL, "Validation of the Korean Stroop test in diagnosis of minimal hepatic encephalopathy" 9 : 8027-, 2019
3 정재윤, "Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea" 대한의학회 32 (32): 1484-1490, 2017
4 Bajaj JS, "The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers" 106 : 1646-1653, 2011
5 Kimer N, "Systematic review with meta-analysis : the effects of rifaximin in hepatic encephalopathy" 40 : 123-132, 2014
6 Azoulay D, "Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis" 35 : 590-597, 2001
7 Tandon P, "Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics" 13 : 1189-1196, 2015
8 Sidhu SS, "Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy" 36 : 378-385, 2016
9 Bass NM, "Rifaximin treatment in hepatic encephalopathy" 362 : 1071-1081, 2010
10 Bajaj JS, "Review article : the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism(ISHEN)consensus statement" 33 : 739-747, 2011
1 Gwon DI, "Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study" 26 : 1589-1595, 2015
2 Yoon EL, "Validation of the Korean Stroop test in diagnosis of minimal hepatic encephalopathy" 9 : 8027-, 2019
3 정재윤, "Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea" 대한의학회 32 (32): 1484-1490, 2017
4 Bajaj JS, "The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers" 106 : 1646-1653, 2011
5 Kimer N, "Systematic review with meta-analysis : the effects of rifaximin in hepatic encephalopathy" 40 : 123-132, 2014
6 Azoulay D, "Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis" 35 : 590-597, 2001
7 Tandon P, "Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics" 13 : 1189-1196, 2015
8 Sidhu SS, "Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy" 36 : 378-385, 2016
9 Bass NM, "Rifaximin treatment in hepatic encephalopathy" 362 : 1071-1081, 2010
10 Bajaj JS, "Review article : the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism(ISHEN)consensus statement" 33 : 739-747, 2011
11 Tapper EB, "Refining the ammonia hypothesis : a physiology-driven approach to the treatment of hepatic encephalopathy" 90 : 646-658, 2015
12 Bonilha DQ, "Propranolol associated with endoscopic band ligation reduces recurrence of esophageal varices for primary prophylaxis of variceal bleeding : a randomized-controlled trial" 27 : 84-90, 2015
13 Mishra SR, "Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers : a randomized controlled trial" 54 : 1161-1167, 2011
14 Qi XS, "Nonselective beta-blockers in cirrhotic patients with no or small varices : a meta-analysis" 21 : 3100-3108, 2015
15 Als-Nielsen B, "Non-absorbable disaccharides for hepatic encephalopathy : systematic review of randomised trials" 328 : 1046-, 2004
16 Merli M, "Incidence and natural history of small esophageal varices in cirrhotic patients" 38 : 266-272, 2003
17 Guyatt GH, "GRADE : an emerging consensus on rating quality of evidence and strength of recommendations" 336 : 924-926, 2008
18 de Franchis R, "Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop:stratifying risk and individualizing care for portal hypertension" 63 : 743-752, 2015
19 Procaccini NJ, "Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis" 70 : 881-887, 2009
20 Mishra SR, "Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed : a randomised controlled trial" 59 : 729-735, 2010
21 Hung HH, "Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding : a randomized controlled trial" 56 : 1025-1032, 2012
22 Sarin SK, "Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis : a randomized controlled trial" 7 : 248-256, 2013
23 European Association for the Study of the Liver, "EASL clinical practice guidelines on nutrition in chronic liver disease" 70 : 172-193, 2019
24 Puente A, "Drugs plus ligation to prevent rebleeding in cirrhosis : an updated systematic review" 34 : 823-833, 2014
25 Qiao W, "Cyanoacrylate injection versus band ligation in the endoscopic management of acute gastric variceal bleeding: meta-analysis of randomized, controlled studies based on the PRISMA statement" 94 : e1725-, 2015
26 Luo M, "Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy : a meta-analysis" 23 : 1250-1257, 2011
27 Park SW, "Changes in cardiac varices and their clinical significance after eradication of esophageal varices by band ligation" 2016 : 2198163-, 2016
28 "Cause-of-death statistics in 2018 in the Republic of Korea" Statistics Korea
29 Bhardwaj A, "Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis : a randomised placebo-controlled trial" 66 : 1838-1843, 2017
30 Lockwood AH, "Blood ammonia levels and hepatic encephalopathy" 19 : 345-349, 2004
31 Groszmann RJ, "Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis" 353 : 2254-2261, 2005
32 Garrido M, "An educational tool for the prophylaxis of hepatic encephalopathy" 4 : e000161-, 2017
33 Sharma BC, "A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy" 108 : 1458-1463, 2013
34 Korean Association for the Study of the Liver, "2019 Korean Association for the Study of the Liver clinical practice guidelines for liver cirrhosis: varices, hepatic encephalopathy and related complications" Jin Publishing Co 2019